| 2.075 0.355 (20.64%) | 11-06 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.94 | 1-year : | 3.56 |
| Resists | First : | 2.52 | Second : | 3.05 |
| Pivot price | 2  |
|||
| Supports | First : | 1.65 | Second : | 1.38 |
| MAs | MA(5) : | 1.89 |
MA(20) : | 2.05 |
| MA(100) : | 3.75 |
MA(250) : | 5.09 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 36.3 |
D(3) : | 21 |
| RSI | RSI(14): 44.1 |
|||
| 52-week | High : | 9.28 | Low : | 1.65 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ASPI ] has closed below upper band by 33.8%. Bollinger Bands are 66.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.08 - 2.1 | 2.1 - 2.11 |
| Low: | 1.72 - 1.73 | 1.73 - 1.74 |
| Close: | 2.05 - 2.08 | 2.08 - 2.1 |
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Thu, 05 Nov 2026
ASP Isotopes (Nasdaq:ASPI) - Stock Analysis - Simply Wall St
Fri, 16 Oct 2026
To cover stock-award taxes, ASP Isotopes (ASPI) COO sells 22,500 shares under a trading plan. - Stock Titan
Thu, 01 Oct 2026
Director buys 15,000 shares in ASP Isotopes (ASPI), bringing his direct holdings to 675,222. - Stock Titan
Fri, 25 Sep 2026
After two 50,000-share sales, ASP Isotopes (ASPI) director Todd Wider proposes another sale. - Stock Titan
Thu, 10 Sep 2026
ASP Isotopes (ASPI) COO sells shares to cover taxes - Stock Titan
Sun, 19 Jul 2026
Reframing ASP Isotopes' (ASPI) Long-Term Strategy - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 153 (M) |
| Shares Float | 133 (M) |
| Held by Insiders | 10.4 (%) |
| Held by Institutions | 48.1 (%) |
| Shares Short | 26,460 (K) |
| Shares Short P.Month | 25,480 (K) |
| EPS | -1.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.02 |
| Profit Margin | 0 % |
| Operating Margin | -667.5 % |
| Return on Assets (ttm) | -17.1 % |
| Return on Equity (ttm) | -90.4 % |
| Qtrly Rev. Growth | 327.6 % |
| Gross Profit (p.s.) | 0.03 |
| Sales Per Share | 0.2 |
| EBITDA (p.s.) | -0.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -68 (M) |
| Levered Free Cash Flow | -29 (M) |
| PE Ratio | -1.4 |
| PEG Ratio | 0 |
| Price to Book value | 1.02 |
| Price to Sales | 10.31 |
| Price to Cash Flow | -4.7 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|